Abingworth as of March 31, 2013
Portfolio Holdings for Abingworth
Abingworth holds 18 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation (AMRN) | 36.9 | $60M | 8.1M | 7.40 | |
| Clovis Oncology | 16.6 | $27M | 939k | 28.66 | |
| Supernus Pharmaceuticals (SUPN) | 12.5 | $20M | 3.6M | 5.62 | |
| Alnylam Pharmaceuticals (ALNY) | 7.7 | $13M | 514k | 24.37 | |
| Astex Pharmaceuticals | 7.2 | $12M | 2.6M | 4.56 | |
| OncoGenex Pharmaceuticals | 4.2 | $6.8M | 604k | 11.31 | |
| Incyte Corporation (INCY) | 4.2 | $6.8M | 290k | 23.40 | |
| ISIS Pharmaceuticals | 2.8 | $4.5M | 268k | 16.93 | |
| Zogenix | 2.6 | $4.2M | 2.3M | 1.79 | |
| Anthera Pharmaceuticals | 1.4 | $2.2M | 3.5M | 0.64 | |
| Exelixis (EXEL) | 1.2 | $1.9M | 415k | 4.62 | |
| Hyperion Therapeutics | 0.9 | $1.5M | 63k | 23.41 | |
| alexza Pharmaceuticals | 0.8 | $1.3M | 287k | 4.37 | |
| Cornerstone Therapeutics | 0.4 | $597k | 85k | 7.04 | |
| Zalicus | 0.3 | $562k | 864k | 0.65 | |
| AVANIR Pharmaceuticals | 0.2 | $308k | 113k | 2.74 | |
| Cardiome Pharma Corp | 0.1 | $173k | 481k | 0.36 | |
| EntreMed | 0.1 | $144k | 71k | 2.04 |
